Denver HIV Risk Score
Calculate the Denver HIV Risk Score (DHRS) to assess a patient's likelihood of HIV infection based on age, sex, sexual practices, injection drug use, and race. Free clinical screening tool.
About This Calculator
The Denver HIV Risk Score (DHRS) is a validated clinical prediction tool for identifying patients at elevated risk of undiagnosed HIV infection in emergency department settings. Developed by Haukoos and colleagues and published in the American Journal of Epidemiology (2012), the score uses five easily obtainable patient characteristics — age, sex, sexual practices, injection drug use history, and race/ethnicity — to produce a composite score that correlates with HIV prevalence. The tool emerged from research showing that non-targeted HIV screening had modest effectiveness, and that a simple risk-based approach could identify significantly more HIV infections per test performed. This makes the calculator particularly valuable in clinical environments where testing resources are limited or where patients may not volunteer risk information unprompted.
The scoring system assigns points across five domains based on logistic regression coefficients from the original derivation cohort. Age is scored incrementally from 0 to 20 points depending on the age group, with middle-aged adults (33-54) receiving the highest scores. Male sex contributes 9 points. Sexual practice is weighted heavily — having sex with a male adds 22 points, while receptive anal intercourse adds 8 points. Vaginal intercourse actually subtracts 10 points, reflecting a lower independent risk. Injection drug use contributes 6 points. Race/ethnicity is optional and adds up to 11 points. Total scores typically range from negative values (a young woman with no risk factors who has vaginal intercourse) to over 60. The score is categorized into Low Risk (≤20, prevalence <0.5%), Moderate Risk (21-30, prevalence 0.5-1%), and High Risk (≥31, prevalence >1%), with corresponding testing recommendations for each category.
Regional Notes
United States: The CDC recommends routine opt-out HIV screening for all patients aged 13-64 in healthcare settings. The Denver HIV Risk Score is commonly used in US emergency departments as a targeted screening adjunct to the universal screening recommendation when resources are constrained. The score was derived and validated in US urban ED populations (Denver, Colorado).
India: India has the third-largest HIV epidemic in the world with approximately 2.4 million people living with HIV (NACO 2023). NACO's targeted intervention approach focuses on high-risk groups including female sex workers, men who have sex with men (MSM), injecting drug users, and transgender persons. The Denver HIV Risk Score can complement existing risk assessment protocols in Indian clinical settings, particularly in high-prevalence states.
United Kingdom: BHIVA guidelines recommend HIV testing in all healthcare settings where HIV prevalence exceeds 0.2%. The Denver HIV Risk Score is used in some UK sexual health clinics and emergency departments to identify high-risk patients for testing, alongside indicator-condition-based testing for conditions such as tuberculosis, lymphoma, and hepatitis B/C.
Frequently Asked Questions
What is the Denver HIV Risk Score?
The Denver HIV Risk Score (DHRS) is a validated clinical screening tool developed by Haukoos et al. in 2012. It uses patient demographics and risk behaviors (age, sex, sexual practices, injection drug use, and race) to quantify the likelihood of undiagnosed HIV infection. Scores range from well below zero to over 60, with higher scores indicating greater HIV prevalence risk. It was derived and validated in emergency department populations and is designed to identify patients who would benefit most from HIV testing.
How is the Denver HIV Risk Score calculated?
The score is calculated by summing points from five domains: age group (6 points for 22-25, 8 for 26-32, 13 for 33-46, 20 for 47-54, 4 for 55-60, 0 otherwise), sex (9 points for male), sexual practice (22 for sex with a male, 8 for receptive anal intercourse, -10 for vaginal intercourse, 0 for none), injection drug use (6 points if yes), and race (11 for Black, 6 for Hispanic, 10 for American Indian/Alaska Native, 8 for Native Hawaiian/Other Pacific Islander, 0 for White or not specified).
What do the Denver HIV Risk Score results mean?
A score of 20 or below indicates Low Risk with an estimated HIV prevalence below 0.5%. A score of 21-30 indicates Moderate Risk with prevalence of 0.5-1%, and the patient should be tested at least once. A score of 31 or above indicates High Risk with prevalence above 1%, and testing is strongly recommended with regular follow-up. The score is a screening tool, not a diagnostic test — all patients with positive screening should undergo confirmatory HIV testing.
Is the Denver HIV Risk Score accurate?
The Denver HIV Risk Score has been validated in multiple emergency department studies. The original derivation study (Haukoos et al., 2012, American Journal of Epidemiology) showed that using the score to target HIV testing identified significantly more HIV infections per test performed compared to non-targeted screening. A shortened version (without sexual practice questions) also performs well, making it a flexible tool for various clinical settings. Like all screening tools, it is most effective when used as part of a comprehensive HIV testing strategy following local public health guidelines.
Who should use the Denver HIV Risk Score calculator?
This calculator is designed for healthcare professionals including emergency department physicians, primary care providers, nurse practitioners, and public health workers who need to identify patients at elevated HIV risk for targeted screening. In the US, the CDC recommends routine HIV screening for all patients aged 13-64, and the Denver score helps prioritize testing when resources are limited. In India and the UK, similar targeted screening approaches are used in high-prevalence settings and STI clinics.
Can the Denver HIV Risk Score be used without asking about sexual practices?
Yes, a shortened version of the Denver HIV Risk Score (DHRS-S) omits the detailed sexual practice question and uses only the question about sex with a male. The abbreviated version performed similarly to the full score in validation studies and may be more practical in busy clinical settings where detailed sexual history is difficult to obtain. Our calculator includes both options via the sexual practice field, allowing clinicians to choose the appropriate level of detail for their setting.
What are the high-risk behaviors for HIV transmission?
High-risk behaviors for HIV transmission include unprotected anal or vaginal intercourse, having multiple sexual partners, being a man who has sex with men (MSM), injection drug use with shared needles, and having other sexually transmitted infections (STIs) which increase HIV acquisition risk. The Denver HIV Risk Score incorporates several of these factors. Globally, prevention strategies include consistent condom use, pre-exposure prophylaxis (PrEP) for high-risk individuals, needle exchange programs, and regular HIV testing.
How should healthcare providers use the Denver HIV Risk Score in India, the US, and the UK?
In the United States, the CDC recommends routine opt-out HIV screening for all patients aged 13-64; the Denver score can help prioritize testing in resource-limited settings like emergency departments. In India, NACO (National AIDS Control Organization) recommends targeted testing for high-risk groups including female sex workers, MSM, injecting drug users, and transgender persons; the Denver score provides an evidence-based framework for risk stratification. In the UK, the British HIV Association (BHIVA) guidelines recommend HIV testing in all high-prevalence areas (prevalence above 0.2%) and in GUM/STI clinics, where the Denver score can complement current testing protocols.